Windlas Biotech Limited

NSE:WINDLAS India Drug Manufacturers - Specialty & Generic

Market Cap

$178.00 Million

₹15.42 Billion INR

Market Cap Rank

#20097 Global

#1021 in India

Share Price

₹731.40

Change (1 day)

+0.81%

52-Week Range

₹725.55 - ₹1084.10

All Time High

₹1144.25

Windlas Biotech Limited - Asset Resilience Ratio

Latest as of September 2025: 32.06%

Windlas Biotech Limited (WINDLAS) has an Asset Resilience Ratio of 32.06% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

₹2.61 Billion

Cash + Short-term Investments

Total Assets

₹8.14 Billion

All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2018–2025)

This chart shows how Windlas Biotech Limited's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.

Liquid Assets Composition Over Time

This chart breaks down Windlas Biotech Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	₹0.00	0%
Short-term Investments	₹2.61 Billion	32.06%
Total Liquid Assets	₹2.61 Billion	32.06%

Asset Resilience Insights

Very High Liquidity: Windlas Biotech Limited maintains exceptional liquid asset reserves at 32.06% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.